Published in J Exp Med on December 04, 2000
The many roles of FAS receptor signaling in the immune system. Immunity (2009) 4.67
Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med (2002) 4.67
NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol (2001) 4.55
Dangerous liaisons at the virological synapse. J Clin Invest (2004) 2.23
NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol (2004) 1.71
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol (2012) 1.71
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med (2001) 1.62
CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med (2002) 1.56
T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med (2004) 1.55
Death receptors couple to both cell proliferation and apoptosis. J Clin Invest (2002) 1.35
Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med (2008) 1.26
Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock (2004) 1.22
c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. J Exp Med (2004) 1.12
Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J Immunol (2005) 1.01
Countering the 'counterattack' hypothesis. Nat Med (2001) 1.01
Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol (2003) 0.99
Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst (2008) 0.99
HIV/SIV infection primes monocytes and dendritic cells for apoptosis. PLoS Pathog (2011) 0.98
Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One (2011) 0.96
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically. Am J Pathol (2007) 0.96
Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol (2007) 0.96
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. J Mol Cell Cardiol (2006) 0.95
Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO. J Immunol (2012) 0.92
Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood (2006) 0.90
Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model. Clin Exp Immunol (2014) 0.86
c-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival. Eur J Immunol (2008) 0.86
Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation. Immunology (2003) 0.86
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency. Hum Gene Ther (2008) 0.86
Selective regulation of CD40 expression in murine dendritic cells by thiol antioxidants. Immunology (2003) 0.85
Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance. Infect Immun (2013) 0.85
Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies. Immunology (2008) 0.81
Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. PLoS One (2011) 0.81
Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. Am J Pathol (2011) 0.81
Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi. Infect Immun (2006) 0.80
Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation. Immunology (2010) 0.80
Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets (2010) 0.79
Role of early- or late-phase activation of p38 mitogen-activated protein kinase induced by tumour necrosis factor-alpha or 2,4-dinitrochlorobenzene during maturation of murine dendritic cells. Immunology (2003) 0.78
Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol (2003) 0.78
Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice. Immunology (2006) 0.77
NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation. Nucleic Acids Res (2014) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Inhibition of death receptor signals by cellular FLIP. Nature (1997) 9.58
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity (1998) 5.20
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
Fas and FasL in the homeostatic regulation of immune responses. Immunol Today (1995) 3.24
The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol (2000) 3.12
Fas transduces activation signals in normal human T lymphocytes. J Exp Med (1993) 3.04
Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell (1999) 2.89
Caspase activation is required for T cell proliferation. J Exp Med (1999) 2.74
Inhibition of fas death signals by FLIPs. Curr Opin Immunol (1998) 2.67
Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med (1998) 2.66
Expression of the Fas ligand in cells of T cell lineage. J Immunol (1995) 2.54
Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med (1998) 2.47
Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (1995) 2.43
The role of Fas in autoimmune diabetes. Cell (1997) 2.30
Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci U S A (1997) 2.02
Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry (1994) 1.60
Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc Natl Acad Sci U S A (1995) 1.40
Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol (1994) 1.39
Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med (1997) 1.33
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood (2000) 1.25
Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol (1998) 1.22
Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J Immunol (1999) 1.22
Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J Immunol (1999) 1.15
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J Immunol Methods (2000) 1.08
Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today (1998) 0.92
Dendritic cells as natural adjuvants. Methods (1999) 0.85
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
A physical map of the human genome. Nature (2001) 12.39
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Inhibition of death receptor signals by cellular FLIP. Nature (1997) 9.58
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ (2007) 8.85
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med (1999) 7.41
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med (1998) 6.36
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (2001) 6.32
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med (1999) 6.27
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 6.23
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (1996) 6.02
Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med (1970) 5.90
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (1994) 5.58
Contigs built with fingerprints, markers, and FPC V4.7. Genome Res (2000) 5.56
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 4.92
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol (1999) 4.87
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science (2001) 4.79
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol (2001) 4.55
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol (1999) 4.53
Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ (2006) 4.16
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med (1991) 4.15
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med (1998) 3.72
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol (2001) 3.59
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med (2000) 3.43
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med (1998) 3.17
The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol (2000) 3.12
MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem (1998) 3.09
Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity (1998) 3.03
Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A (2000) 3.03
Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med (2000) 2.99
Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A (2000) 2.87
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science (1998) 2.84
TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol (2000) 2.80
Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol (2001) 2.77
Caspase activation is required for T cell proliferation. J Exp Med (1999) 2.74
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med (2000) 2.69
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol (2000) 2.66
Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med (1998) 2.66
Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem (1985) 2.62
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity (1997) 2.60
A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell (1987) 2.58
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J (1993) 2.50
The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ (2007) 2.49
The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol (2001) 2.43
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci (1992) 2.40
Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9. Nature (1982) 2.35
A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30
Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol (1998) 2.27
The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J Cell Biol (1994) 2.20
The sequence and topology of human complement component C9. EMBO J (1985) 2.18
Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ (2006) 2.16
Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol (1996) 2.14
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med (2001) 2.12
Plaque assay of Herpesvirus hominis on human embryonic fibroblasts. Proc Soc Exp Biol Med (1969) 2.09
Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol (2001) 2.04
The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci (1997) 2.02
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci U S A (1999) 1.99
Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol (1998) 1.97
Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A (1982) 1.96
Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A (2001) 1.95
A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol (2001) 1.90
Ceramide enables fas to cap and kill. J Biol Chem (2001) 1.88
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol (2001) 1.87
Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci U S A (1989) 1.85
Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology (2001) 1.83
A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med (2000) 1.83
Characterization of two receptors for TRAIL. FEBS Lett (1997) 1.82
Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med (1995) 1.81
Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med (1996) 1.80
Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry (1991) 1.77
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A (1998) 1.74
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci U S A (1986) 1.73
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol (1985) 1.72
Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem (1982) 1.70
Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature (1986) 1.70
Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev (1988) 1.68
Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol (1999) 1.68
The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett (1995) 1.67
Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett (2001) 1.66
Monokine production by microglial cell clones. Eur J Immunol (1989) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood (2000) 1.63